|
|
Article: Positive data reported from Isolagen process study in facial contour deformities.
- Article from:
- Pharma Business Week
- Article date:
- August 16, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 AUG 16 - (NewsRx.com & NewsRx.net) -- Isolagen, Inc., (ILE) released 6-month marker data of the first Isolagen process phase III study assessing improvement for facial contour deformities, indicating a positive response in 82% of the Isolagen-treated patients who were evaluated.
On July 21, 2004, the company announced the commencement of two additional phase III trials under a Special Protocol Assessment with the U.S. Food and Drug Administration (FDA) for treatment of facial wrinkles only.
These simultaneous pivotal phase III trials are designed to further assess the safety and effectiveness of the Isolagen Process and provide the type of data ...